Accumulation of Tregs is driven by the chemokine C-C motif chemokine 22 (CCL22) produced predominantly by the tumor, as well as by tumor-associated macrophages and dendritic cells in the TME via interaction with its counter receptor, chemokine receptor 4 (CCR4), expressed on Tregs [77]. This evidence concerns the gene CCL22 and neoplasm.